Neuropeptides
Volume 44, Issue 3 , Pages 225-232, June 2010

Modulation of feeding and locomotion through mu and delta opioid receptor signaling in the nucleus accumbens

  • Yoshihiro Katsuura
  • ,
  • Sharif A. Taha

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: Department of Physiology, University of Utah School of Medicine, 420 Chipeta Way, Suite 1700, Salt Lake City, UT 84108, United States. Tel.: +1 801 585 6214.

Department of Physiology, University of Utah School of Medicine, Salt Lake City, UT 84108, United States

Received 30 September 2009; accepted 4 December 2009. published online 31 December 2009.

Abstract 

Opioid signaling has been strongly implicated in driving palatable food consumption. The nucleus accumbens (NAcc) is one important site of this effect; hyperphagia elicited by administration of exogenous mu opioid receptor (MOR) ligands in this brain region has been well documented. However, the role that endogenous opioid ligands in the NAcc play in controlling food intake remains poorly understood. Enkephalins, which signal through both the MOR and delta opioid receptor (DOR), are highly expressed within a subset of NAcc neurons, and have been shown to be sensitive to manipulations of diet and motivation. To investigate a potential role for these signaling molecules in regulating palatability-driven consumption, we measured high fat chow intake in rats following a series of pharmacological manipulations of NAcc opioid signaling. NAcc infusion of the MOR agonist [d-Ala2, N-MePHe4, Gly-ol]-enkephalin (DAMGO) robustly increased palatable food intake, as has previously been demonstrated. In contrast, neither infusion of Met-enkephalin, its synthetic analogue [d-Ala2] Met-enkephalin (DALA) nor the DOR-specific ligand [d-Pen2, Pen5]-enkephalin (DPDPE) had significant effects on food intake. However, when administered in combination with DAMGO, DPDPE significantly suppressed the magnitude of DAMGO-evoked feeding. Further analysis of DPDPE effects revealed that the drug strongly increased locomotor activity. Suppressive effects on feeding, then, may have occurred through competition between feeding and locomotion for behavioral expression.

Abbreviations: β-FNA, beta-funaltrexamine, DADLE, [d-Ala2, d-Leu5]-enkephalin, DALA, [d-Ala2] Met-enkephalin, DALCE, [d-AlaLeu5, Cys6]-enkephalin, DAMGO, [d-Ala2N-MePHe4, Gly-ol]-enkephalin, DOR, delta opioid receptor, DPDPE, [d-Pen2Pen5]-enkephalin, KOR, kappa opioid receptor, MOR, mu opioid receptor, NAcc, nucleus accumbens, Nor-BNI, Nor-binaltorphimine, PPENK, preproenkephalin

Keywords: Palatability, Food intake, Consumption, Enkephalin, Nucleus accumbens

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0143-4179(09)00141-3

doi:10.1016/j.npep.2009.12.002

Neuropeptides
Volume 44, Issue 3 , Pages 225-232, June 2010